Life Sciences Archives - Page 7 of 22 - Becker's Hospital Review

Eli Lilly GLP-1 pill shines in trial | Brain tumor, ketamine drugs approved | GSK gets $370M in patent settlement | FDA vaccine chief returns

August 13, 2025 1. FDA approves brain tumor drug targeting new mutation Full story 2. Eli Lilly's daily GLP-1 pill sheds 27 pounds in trial Full story 3. Underresourced and overburdened: How rural hospitals can better support clinical teams here.…

RFK Jr. cancels $500M in vaccine contracts | Blood cancer therapy denied approval | CMS floats GLP-1 coverage | FDA's top vaccine, gene therapy official resigns

August 6, 2025 1. FDA denies approval for Regeneron blood cancer therapy Full story 2. RFK Jr. cancels $500M in mRNA vaccine contracts Full story 3. Stop overtime creep: Find efficiency tips from Baptist MD Anderson's team here. 4. CMS…

Roche halts gene therapy shipments | Blocks to NIH grants walked back | Patient death not tied to gene therapy | Sun Pharma fails inspection

July 30, 2025 1. Roche pauses gene therapy shipments Full story 2. White House walks back NIH grant blocks Full story 3. Less paperwork, more patient care — how AI is transforming the clinician experience: here. 4. Death of 8-year-old…

NIH, FDA cuts threaten drug approvals | Sarepta halts gene therapy shipments | Pfizer to ration syphilis treatment | Potential cancer drug-Alzheimer's connection

July 23, 2025 1. Cuts to NIH, FDA could slash drug approvals: 5 notes Full story 2. Sarepta reverses course, halts gene therapy shipments following FDA request Full story 3. Real-time triage, smarter workflow. Inspira Health's ED turnaround and what…

US drugmaker ends operations | GLP-1s may raise testosterone | CVS faces $949M judgement | HHS layoffs resume

July 16, 2025 1. US drugmaker shutters operations, recalls medications Full story 2. AstraZeneca drug lowers blood pressure: Study Full story 3. Shared cleaning roles are slowing care and adding risk. See what top systems do instead here. 4. HHS…

Common drug may cap cancer treatment success | RKF sued over COVID changes | Novartis drug fails trial | HHS panel backs RSV shot

July 9, 2025 1. Common drug may limit cancer treatment's efficacy: Study Full story 2. Novartis drug fails late-stage trial for artery disease Full story 3. Impossible to solve this with manpower alone: How systems are rethinking Rx access, here.…

Study probes GLP-1, pancreatitis link | Moderna combo shot clears hurdle | Just 8% of GLP-1 users utilize long-term | The best, worst states for healthcare

July 2, 2025 1. 3 osteoporosis medications linked to heart attack risk: 5 notes Full story 2. UK probes link between GLP-1s, acute pancreatitis Full story 3. Denials are hitting margins hard. How AI is helping health systems fight back…

CIDRAP launches vaccine committee | NIH cuts mean delays for cancer treatments | FDA drug official to retire | GLP-1 cost, access: 4 updates

June 25, 2025 1. CIDRAP launches vaccine committee to replace ACIP: 4 notes Full story 2. NIH cuts mean delays for specialized cancer treatments: 5 notes Full story 3. AI in cancer care: Find out where health systems are seeing…

Gene therapy treatment paused after 2nd death | Eli Lilly updates Zepbound dosing | New pill cuts cholesterol 30% | FDA OKs RSV antibody

June 18, 2025 1. Sarepta halts gene therapy treatment after 2nd death Full story 2. FDA OKs antibody to protect against RSV in infants Full story 3. Avoid the hidden cost of lab sell-offs. 5 data-driven reasons to keep it,…

FDA taps AI for faster drug approvals | Vaccines may cut antibiotic use | Semaglutide linked to eye disease risk | Healthcare workforce by state

June 11, 2025 1. Vaccines could slash antibiotic use by 2.5B doses annually: Report Full story 2. FDA employs AI in effort to accelerate drug approvals Full story 3. Training gaps threaten the quality of telehealth care delivery. Learn how…